These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 29752432)
21. Modular optimization of multi-gene pathways for fumarate production. Chen X; Zhu P; Liu L Metab Eng; 2016 Jan; 33():76-85. PubMed ID: 26241189 [TBL] [Abstract][Full Text] [Related]
22. Modular Engineering of Tyrosol Production in Escherichia coli. Yang H; Xue Y; Yang C; Shen W; Fan Y; Chen X J Agric Food Chem; 2019 Apr; 67(14):3900-3908. PubMed ID: 30873833 [TBL] [Abstract][Full Text] [Related]
23. Type IIs restriction based combinatory modulation technique for metabolic pathway optimization. Ye L; He P; Li Q; Zhang X; Bi C Microb Cell Fact; 2017 Mar; 16(1):47. PubMed ID: 28302121 [TBL] [Abstract][Full Text] [Related]
24. Modular pathway engineering for resveratrol and piceatannol production in engineered Escherichia coli. Shrestha A; Pandey RP; Pokhrel AR; Dhakal D; Chu LL; Sohng JK Appl Microbiol Biotechnol; 2018 Nov; 102(22):9691-9706. PubMed ID: 30178203 [TBL] [Abstract][Full Text] [Related]
25. Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli. Ying H; Tao S; Wang J; Ma W; Chen K; Wang X; Ouyang P Microb Cell Fact; 2017 Mar; 16(1):52. PubMed ID: 28347340 [TBL] [Abstract][Full Text] [Related]
26. Intermediate-sensor assisted push-pull strategy and its application in heterologous deoxyviolacein production in Escherichia coli. Fang M; Wang T; Zhang C; Bai J; Zheng X; Zhao X; Lou C; Xing XH Metab Eng; 2016 Jan; 33():41-51. PubMed ID: 26506462 [TBL] [Abstract][Full Text] [Related]
27. Pathway engineering for efficient biosynthesis of violaxanthin in Escherichia coli. Takemura M; Kubo A; Higuchi Y; Maoka T; Sahara T; Yaoi K; Ohdan K; Umeno D; Misawa N Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9393-9399. PubMed ID: 31673744 [TBL] [Abstract][Full Text] [Related]
28. Genome mining of astaxanthin biosynthetic genes from Sphingomonas sp. ATCC 55669 for heterologous overproduction in Escherichia coli. Ma T; Zhou Y; Li X; Zhu F; Cheng Y; Liu Y; Deng Z; Liu T Biotechnol J; 2016 Feb; 11(2):228-37. PubMed ID: 26580858 [TBL] [Abstract][Full Text] [Related]
29. Metabolic engineering probiotic yeast produces 3S, 3'S-astaxanthin to inhibit B16F10 metastasis. Tseng CC; Lin YJ; Liu W; Lin HY; Chou HY; Thia C; Wu JH; Chang JS; Wen ZH; Chang JJ; David Wang HM Food Chem Toxicol; 2020 Jan; 135():110993. PubMed ID: 31765702 [TBL] [Abstract][Full Text] [Related]
30. Metabolic engineering a yeast to produce astaxanthin. Lin YJ; Chang JJ; Lin HY; Thia C; Kao YY; Huang CC; Li WH Bioresour Technol; 2017 Dec; 245(Pt A):899-905. PubMed ID: 28931206 [TBL] [Abstract][Full Text] [Related]
31. Production of the Marine Carotenoid Astaxanthin by Metabolically Engineered Corynebacterium glutamicum. Henke NA; Heider SA; Peters-Wendisch P; Wendisch VF Mar Drugs; 2016 Jun; 14(7):. PubMed ID: 27376307 [TBL] [Abstract][Full Text] [Related]
32. Highly efficient biosynthesis of astaxanthin in Saccharomyces cerevisiae by integration and tuning of algal crtZ and bkt. Zhou P; Ye L; Xie W; Lv X; Yu H Appl Microbiol Biotechnol; 2015 Oct; 99(20):8419-28. PubMed ID: 26156241 [TBL] [Abstract][Full Text] [Related]
33. Combinatory optimization of chromosomal integrated mevalonate pathway for β-carotene production in Escherichia coli. Ye L; Zhang C; Bi C; Li Q; Zhang X Microb Cell Fact; 2016 Dec; 15(1):202. PubMed ID: 27905930 [TBL] [Abstract][Full Text] [Related]
34. Engineering Escherichia coli for canthaxanthin and astaxanthin biosynthesis. Cheng Q; Tao L Methods Mol Biol; 2012; 892():143-58. PubMed ID: 22623300 [TBL] [Abstract][Full Text] [Related]
35. L-Cysteine Production in Escherichia coli Based on Rational Metabolic Engineering and Modular Strategy. Liu H; Fang G; Wu H; Li Z; Ye Q Biotechnol J; 2018 May; 13(5):e1700695. PubMed ID: 29405609 [TBL] [Abstract][Full Text] [Related]
36. Metabolic engineering of astaxanthin production in tobacco flowers. Mann V; Harker M; Pecker I; Hirschberg J Nat Biotechnol; 2000 Aug; 18(8):888-92. PubMed ID: 10932161 [TBL] [Abstract][Full Text] [Related]
37. Construction of polyketide overproducing Escherichia coli strains via synthetic antisense RNAs based on in silico fluxome analysis and comparative transcriptome analysis. Meng HL; Xiong ZQ; Song SJ; Wang J; Wang Y Biotechnol J; 2016 Mar; 11(4):530-41. PubMed ID: 26709503 [TBL] [Abstract][Full Text] [Related]
38. Combinatorial pathway optimization in Escherichia coli by directed co-evolution of rate-limiting enzymes and modular pathway engineering. Lv X; Gu J; Wang F; Xie W; Liu M; Ye L; Yu H Biotechnol Bioeng; 2016 Dec; 113(12):2661-2669. PubMed ID: 27316379 [TBL] [Abstract][Full Text] [Related]
39. Metabolic engineering of indole pyruvic acid biosynthesis in Escherichia coli with tdiD. Zhu Y; Hua Y; Zhang B; Sun L; Li W; Kong X; Hong J Microb Cell Fact; 2017 Jan; 16(1):2. PubMed ID: 28049530 [TBL] [Abstract][Full Text] [Related]
40. The chemistry of novel xanthophyll carotenoids. Jackson H; Braun CL; Ernst H Am J Cardiol; 2008 May; 101(10A):50D-57D. PubMed ID: 18474275 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]